U.S. Biotech Stock News

Southwest Airlines (NYSE:LUV) is shifting from open seating to assigned seating after more than 50 years. The company plans to introduce premium seating options and a segmented pricing and fare structure. This overhaul aims to reshape the customer experience and reposition the airline within the industry. For an airline long known for its single cabin and open seating model, this is a major reset in how Southwest Airlines presents its product and prices its seats. You are now looking at...

AdaptHealth Corp previously announced a definitive five-year agreement to become the exclusive provider of home medical equipment and supplies for a large national healthcare system serving more than 10 million members, with the contract expected to generate over US$1.00 billion in revenue. The company highlighted that this partnership should add at least US$200 million in new annual revenue once fully ramped, while supporting efforts to improve profitability, strengthen its core business...

Autoliv has recently drawn attention as analysts highlighted its consistent record of positive earnings surprises and pointed to a positive Earnings ESP ahead of the December 2025 quarter results expected on January 30, 2026. This growing analyst optimism, backed by several quarters of outperformance versus consensus expectations, is shaping market expectations for the company’s near-term earnings profile. We’ll now examine how this rising confidence in Autoliv’s potential to surpass...

Recently, analyst service Zacks assigned Bunge Global a Rank #2 (Buy) with a Momentum Style Score of B, reflecting strong momentum characteristics and mostly positive earnings estimate revisions. This combination of upbeat momentum metrics and improving earnings expectations has strengthened investor confidence in Bunge Global’s near-term prospects. We’ll now examine how Bunge Global’s positive earnings estimate revisions shape its investment narrative for investors assessing the company’s...

Hewlett Packard Enterprise (NYSE:HPE) and New Zealand telco 2degrees have agreed to build a private AI platform using HPE Private Cloud AI. The partnership focuses on AI driven analytics, secure on premises cloud infrastructure, and data sovereignty under New Zealand jurisdiction. The initiative is aimed at improving 2degrees' network reliability, data security, and technology agility for local customers. For investors watching NYSE:HPE, this move comes with the shares at $21.37 and a mixed...

If you are wondering whether Zions Bancorporation National Association is fairly priced or offering value right now, you are in the right place to break that question down with numbers. The stock last closed at US$59.18, with returns of a 0.7% decline over 7 days, a 0.6% decline over 30 days, a 0.1% decline year to date, and gains of 5.9% over 1 year, 27.5% over 3 years, and 57.0% over 5 years. Together, these figures give you a mixed picture of recent sentiment and longer term...

Figure Technology Solutions (NasdaqGS:FIGR) has appointed Michael Tannenbaum as Chief Executive Officer and Macrina Kgil as Treasurer. The leadership changes follow the company’s recent IPO and corporate reorganization. Both executives bring experience from leading technology and financial services firms to FIGR’s post IPO structure. Figure Technology Solutions focuses on applying technology to financial services, an area that continues to attract attention as lenders, investors and...

If you are wondering whether NCR Voyix at around US$10.50 is a value opportunity or a value trap, you are not alone. The stock is up 6.5% year to date, but its 1 year return of 17.0% and 5 year return of 50.7% show that recent strength follows a much tougher longer term share price record. Recent coverage has focused on NCR Voyix as a standalone software and services business following the separation of NCR into two listed entities. This has shifted attention to how the market prices its...

Calix (CALX) is back in focus after managed service provider Zentro said it is accelerating SmartMDU deployments across major urban markets, which extends Calix’s broadband platform deeper into multifamily properties. See our latest analysis for Calix. At a share price of $55.69, Calix has had a mixed run recently, with a 2.77% 1 day share price return and a 9.86% 90 day share price decline. Its 50.68% 1 year total shareholder return points to stronger momentum over a longer horizon as news...

Ark Invest’s recent US$21.5 million purchase across Coinbase, Circle Internet and Bullish (BLSH) has pulled fresh attention to Bullish, even as bitcoin and the broader crypto market show recent weakness. See our latest analysis for Bullish. Bullish’s share price has softened alongside weaker crypto sentiment, with a 7 day share price return of 8.6% and a 90 day share price return of 34% as the stock pulls back from earlier strength. This suggests recent momentum has faded even after Ark’s...

Enova International (ENVA) heads into today’s Q4 2025 earnings release with analysts expecting year over year growth in EPS and revenue, following two years of consistently topping earnings forecasts. See our latest analysis for Enova International. At a share price of $158.55, Enova International has seen a 32.92% 90 day share price return and a 44.45% 1 year total shareholder return, suggesting momentum has been building ahead of today’s earnings update and recent guidance around expected...

If you are wondering whether Home Depot is still a solid value at around US$386.53 per share, you are not alone. The stock often sits on many investors' watchlists when they think about large US retailers. The share price has returned 1.7% over the last 7 days, 10.5% over the last 30 days, 11.8% year to date, 32.8% over 3 years and 61.7% over 5 years, while the return over the last year sits at a 6.8% decline. Recent attention on Home Depot has focused on how its share price performance...

SBA Communications: Key performance snapshot SBA Communications (SBAC) has drawn investor attention after a period of mixed returns, with the stock roughly flat over the past month and weaker over the past 3 months and year. The company reports annual revenue of US$2.79b and net income of US$856.97m, with both metrics showing single digit annual growth. Recent share performance contrasts with these fundamentals and this may prompt closer review from income and infrastructure focused...

If you are wondering whether United Rentals is still good value after a strong multi year run, this article walks through what the current share price could be implying about the business. The stock last closed at US$911.16, with returns of 10.1% over the past 30 days, 19.4% over 1 year and a very large gain over 5 years. This naturally raises questions about how much upside or downside might be left. Recent moves have come alongside ongoing attention on large scale construction and...

Polaris (NYSE:PII) reported its fourth quarter and full year 2025 results, showing net losses for both periods. The company highlighted revenue growth in key product segments during the year. Quarterly adjusted earnings per share came in better than expected, despite the reported net loss. Polaris, known for off road vehicles, snowmobiles and related power sports equipment, now faces a mixed picture as it reports net losses alongside revenue growth in important product areas. For you as an...

Central Bancompany Inc., based in Jefferson City, Missouri, recently reported fourth-quarter net income of US$107.6 million, or US$0.47 per share, on revenue net of interest expense of US$272.2 million, surpassing analyst expectations. The earnings beat, particularly the stronger-than-forecast revenue net of interest expense, highlights how the bank’s core operations outperformed what the market had been anticipating. With quarterly revenue net of interest expense topping forecasts, we’ll...

Why Ventas Is Back on Investor Radars Ventas (VTR) is drawing fresh attention as its earnings growth, consistent upside surprises, steady revenue profile, and expanded free cash flow are aligned with a confirmed upward share price trend. See our latest analysis for Ventas. Despite a recent 1 month share price return decline of 4.19% and some softness over the last week, Ventas still carries an 8.89% 3 month share price gain and a 26.86% 1 year total shareholder return, which suggests momentum...

TG Therapeutics plans to present new clinical data for BRIUMVI at the upcoming ACTRIMS annual forum. The updates will cover Phase 4 real world infusion experience, pediatric trial designs, and biomarker findings in relapsing multiple sclerosis. The breadth of data is aimed at further defining BRIUMVI's clinical profile beyond previously shared information. TG Therapeutics, trading on NasdaqCM:TGTX, is drawing fresh attention with this planned data package around BRIUMVI. The stock last...

Kymera Therapeutics recently outlined its 2026 preclinical and clinical milestones, highlighting the ongoing Phase 2b BREADTH trial of KT-621 in moderate to severe eosinophilic asthma, positive past Phase 1b data in atopic dermatitis, and progress in partnered programs including an oral IRAK4 degrader with Sanofi. A particularly important element of this update is the advancement of KT-621 as a first-in-class oral STAT6 degrader targeting Type 2 inflammation, alongside collaboration...

Smithfield Foods, NasdaqGS:SFD, has agreed to acquire Nathan's Famous in a move to bring the hot dog brand fully in house. The deal is intended to eliminate licensing fees and give Smithfield direct control over Nathan's premium beef product line. The transaction expands Smithfield's protein portfolio beyond pork into branded beef offerings in the processed meat market. For you as an investor, this puts a well known branded beef business under the same roof as one of the largest pork...

In recent weeks, Vertex Pharmaceuticals has attracted a series of analyst upgrades and favorable research reports highlighting the strength of its cystic fibrosis portfolio and kidney disease pipeline, alongside prior FDA orphan drug status for povetacicept. This cluster of positive opinions underscores how regulatory advantages and a focused therapeutics portfolio can materially influence how investors view a biotech’s prospects. We’ll now examine how this wave of analyst optimism around...

Renasant (RNST) is on investors’ radar after recent share performance, with the stock showing positive returns over the past week, month and past 3 months. This has prompted a closer look at its current valuation. See our latest analysis for Renasant. At a share price of $37.27, Renasant’s recent gains, including a 90 day share price return of 6.42% and a 1 year total shareholder return of 2.14%, point to steady but measured momentum as investors reassess the bank’s risk and growth...

Cardinal Health (CAH) heads into its February 5, 2026 earnings report with investor attention focused on revised forecasts for earnings per share and revenue, as well as expectations around its Pharmaceutical and Medical segment performance. See our latest analysis for Cardinal Health. At a share price of $210.93, Cardinal Health has seen a 29.57% 90 day share price return and a 63.37% 1 year total shareholder return, suggesting momentum has been building ahead of earnings and recent analyst...

What Manchester United (MANU) shareholders may focus on now With no single headline event setting the tone, Manchester United (MANU) shares have quietly moved higher in the past month, alongside a mixed return profile over the past 3 months and year. See our latest analysis for Manchester United. At a share price of $17.64, Manchester United’s recent 11.22% 1 month share price return builds on an 11.79% year to date gain. However, the 3 year total shareholder return of 21.81% and 1 year total...